Cargando…

Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave

BACKGROUND & OBJECTIVES: Serial national level serosurveys in India have provided valuable information regarding the spread of COVID-19 pandemic in the general population, but the impact of the ongoing pandemic on the tribal population in India is not well understood. In this study, we evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kshatri, Jaya Singh, Bhattacharya, Debdutta, Giri, Sidhartha, Palo, Subrata Kumar, Kanungo, Srikanta, Mansingh, Asit, Parai, Debaprasad, Dany, Subha Soumya, Bisoyee, Anjan, Choudhary, Hari Ram, Sinha, Abhinav, Sahoo, Rakesh Kumar, Bhoi, Trilochan, Mohanta, Amiya Ranjan, Ota, Akhila Bihari, Mohanty, Bigyanananda, Sahoo, Uttam Kumar, Pati, Sanghamitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057376/
https://www.ncbi.nlm.nih.gov/pubmed/36629188
http://dx.doi.org/10.4103/ijmr.ijmr_3428_21
_version_ 1785016350431772672
author Kshatri, Jaya Singh
Bhattacharya, Debdutta
Giri, Sidhartha
Palo, Subrata Kumar
Kanungo, Srikanta
Mansingh, Asit
Parai, Debaprasad
Dany, Subha Soumya
Bisoyee, Anjan
Choudhary, Hari Ram
Sinha, Abhinav
Sahoo, Rakesh Kumar
Bhoi, Trilochan
Mohanta, Amiya Ranjan
Ota, Akhila Bihari
Mohanty, Bigyanananda
Sahoo, Uttam Kumar
Pati, Sanghamitra
author_facet Kshatri, Jaya Singh
Bhattacharya, Debdutta
Giri, Sidhartha
Palo, Subrata Kumar
Kanungo, Srikanta
Mansingh, Asit
Parai, Debaprasad
Dany, Subha Soumya
Bisoyee, Anjan
Choudhary, Hari Ram
Sinha, Abhinav
Sahoo, Rakesh Kumar
Bhoi, Trilochan
Mohanta, Amiya Ranjan
Ota, Akhila Bihari
Mohanty, Bigyanananda
Sahoo, Uttam Kumar
Pati, Sanghamitra
author_sort Kshatri, Jaya Singh
collection PubMed
description BACKGROUND & OBJECTIVES: Serial national level serosurveys in India have provided valuable information regarding the spread of COVID-19 pandemic in the general population, but the impact of the ongoing pandemic on the tribal population in India is not well understood. In this study, we evaluated the seroprevalence of COVID-19 antibodies in the tribal population of Odisha post-second wave (September 2021). METHODS: A population-based, age-stratified, cross-sectional study design was adopted for the survey, carried out in seven tribal districts of Odisha from 30(th) August to 16(th) September 2021. A multistage random sampling method was used where serum samples were tested for antibodies against the SARS-CoV-2 nucleocapsid (N) protein in each district, and a weighted seroprevalence with 95 per cent confidence interval (CI) was estimated for each district. RESULTS: A total of 2855 study participants were included from the seven tribal districts of Odisha in the final analysis. The overall weighted seroprevalence was 72.8 per cent (95% CI: 70.1-75.3). Serological prevalence was the highest among 18-44 yr (74.4%, 95% CI: 71.3-77.3) and from Sambalpur district [75.90% (66.90-83.10)]. Among participants, 41.93 per cent had received at least one dose of any COVID-19 vaccine. Kandhamal district had the highest number of fully immunized participants (24.78%), and in Sundergarh district, most of the study participants (58.1%) were unimmunized. INTERPRETATION & CONCLUSIONS: This study found high seroprevalence against SARS-CoV-2 in the tribal population of Odisha. The vaccination coverage is at par with the general population, and efforts to address some knowledge gaps may be needed to improve the coverage in the future.
format Online
Article
Text
id pubmed-10057376
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-100573762023-03-30 Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave Kshatri, Jaya Singh Bhattacharya, Debdutta Giri, Sidhartha Palo, Subrata Kumar Kanungo, Srikanta Mansingh, Asit Parai, Debaprasad Dany, Subha Soumya Bisoyee, Anjan Choudhary, Hari Ram Sinha, Abhinav Sahoo, Rakesh Kumar Bhoi, Trilochan Mohanta, Amiya Ranjan Ota, Akhila Bihari Mohanty, Bigyanananda Sahoo, Uttam Kumar Pati, Sanghamitra Indian J Med Res Programme: Original Article BACKGROUND & OBJECTIVES: Serial national level serosurveys in India have provided valuable information regarding the spread of COVID-19 pandemic in the general population, but the impact of the ongoing pandemic on the tribal population in India is not well understood. In this study, we evaluated the seroprevalence of COVID-19 antibodies in the tribal population of Odisha post-second wave (September 2021). METHODS: A population-based, age-stratified, cross-sectional study design was adopted for the survey, carried out in seven tribal districts of Odisha from 30(th) August to 16(th) September 2021. A multistage random sampling method was used where serum samples were tested for antibodies against the SARS-CoV-2 nucleocapsid (N) protein in each district, and a weighted seroprevalence with 95 per cent confidence interval (CI) was estimated for each district. RESULTS: A total of 2855 study participants were included from the seven tribal districts of Odisha in the final analysis. The overall weighted seroprevalence was 72.8 per cent (95% CI: 70.1-75.3). Serological prevalence was the highest among 18-44 yr (74.4%, 95% CI: 71.3-77.3) and from Sambalpur district [75.90% (66.90-83.10)]. Among participants, 41.93 per cent had received at least one dose of any COVID-19 vaccine. Kandhamal district had the highest number of fully immunized participants (24.78%), and in Sundergarh district, most of the study participants (58.1%) were unimmunized. INTERPRETATION & CONCLUSIONS: This study found high seroprevalence against SARS-CoV-2 in the tribal population of Odisha. The vaccination coverage is at par with the general population, and efforts to address some knowledge gaps may be needed to improve the coverage in the future. Wolters Kluwer - Medknow 2022-08 2023-01-05 /pmc/articles/PMC10057376/ /pubmed/36629188 http://dx.doi.org/10.4103/ijmr.ijmr_3428_21 Text en Copyright: © 2022 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Programme: Original Article
Kshatri, Jaya Singh
Bhattacharya, Debdutta
Giri, Sidhartha
Palo, Subrata Kumar
Kanungo, Srikanta
Mansingh, Asit
Parai, Debaprasad
Dany, Subha Soumya
Bisoyee, Anjan
Choudhary, Hari Ram
Sinha, Abhinav
Sahoo, Rakesh Kumar
Bhoi, Trilochan
Mohanta, Amiya Ranjan
Ota, Akhila Bihari
Mohanty, Bigyanananda
Sahoo, Uttam Kumar
Pati, Sanghamitra
Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
title Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
title_full Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
title_fullStr Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
title_full_unstemmed Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
title_short Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave
title_sort serological survey for sars-cov-2 antibodies among tribal communities of odisha post-second wave
topic Programme: Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057376/
https://www.ncbi.nlm.nih.gov/pubmed/36629188
http://dx.doi.org/10.4103/ijmr.ijmr_3428_21
work_keys_str_mv AT kshatrijayasingh serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT bhattacharyadebdutta serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT girisidhartha serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT palosubratakumar serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT kanungosrikanta serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT mansinghasit serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT paraidebaprasad serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT danysubhasoumya serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT bisoyeeanjan serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT choudharyhariram serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT sinhaabhinav serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT sahoorakeshkumar serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT bhoitrilochan serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT mohantaamiyaranjan serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT otaakhilabihari serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT mohantybigyanananda serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT sahoouttamkumar serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT patisanghamitra serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave
AT serologicalsurveyforsarscov2antibodiesamongtribalcommunitiesofodishapostsecondwave